Idiopathic hyperammonemia following high-dose chemotherapy.
Espinós
J
J
Rifón
J
J
Pérez-Calvo
J
J
Nieto
Y
Y
D000410:Alanine Transaminase / Q000097:blood; D000596:Amino Acids / Q000097:blood; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000532:radiotherapy / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D022124:Hyperammonemia / Q000139:chemically induced*; D008875:Middle Aged; D000068878:Trastuzumab; D016896:Treatment Outcome
D000596:Amino Acids; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000068878:Trastuzumab